Literature DB >> 25208856

Gaps in receipt of regular eye examinations among medicare beneficiaries diagnosed with diabetes or chronic eye diseases.

Frank A Sloan1, Arseniy P Yashkin2, Yiqun Chen2.   

Abstract

OBJECTIVE: To examine a wide range of factors associated with regular eye examination receipt among elderly individuals diagnosed with glaucoma, age-related macular degeneration, or diabetes mellitus (DM).
DESIGN: Retrospective analysis of Medicare claims linked to survey data from the Health and Retirement Study (HRS). PARTICIPANTS: The sample consisted of 2151 Medicare beneficiaries who responded to the HRS.
METHODS: Medicare beneficiaries with ≥ 1 of the 3 study diagnoses were identified by diagnosis codes and merged with survey information. The same individuals were followed for 5 years divided into four 15-month periods. Predictors of the number of periods with an eye examination evaluated were beneficiary demographic characteristics, income, health, cognitive and physical function, health behaviors, subjective beliefs about longevity, the length of the individual's financial planning horizon, supplemental health insurance coverage, eye disease diagnoses, and low vision/blindness at baseline. We performed logit analysis of the number of 15-month periods in which beneficiaries received an eye examination. MAIN OUTCOME MEASURES: The primary outcome measure was the number of 15-month periods with an eye examination.
RESULTS: One third of beneficiaries with the study's chronic diseases saw an eye care provider in all 4 follow-up periods despite having Medicare. One quarter only obtained an eye examination at most during 1 of the four 15-month follow-up periods. Among the 3 groups of patients studied, utilization was particularly low for persons with diagnosed DM and no eye complications. Age, marriage, education, and a higher score on the Charlson index were associated with more periods with an eye examination. Male gender, being limited in instrumental activities of daily living at baseline, distance to the nearest ophthalmologist, and low cognitive function were associated with a reduction in frequency of eye examinations.
CONCLUSIONS: Rates of eye examinations for elderly persons with DM or frequently occurring eye diseases, especially for DM, remain far below recommended levels in a nationally representative sample of persons with health insurance coverage. Several factors, including limited physical and cognitive function and greater distance to an ophthalmologist, but not health insurance coverage, account for variation in regular use.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25208856      PMCID: PMC4338994          DOI: 10.1016/j.ophtha.2014.07.020

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

1.  Undertreatment of glaucoma among black Americans.

Authors:  J C Javitt; A M McBean; G A Nicholson; J D Babish; J L Warren; H Krakauer
Journal:  N Engl J Med       Date:  1991-11-14       Impact factor: 91.245

2.  Patterns of care for open-angle glaucoma in managed care.

Authors:  Allen M Fremont; Paul P Lee; Carol M Mangione; Kanika Kapur; John L Adams; Steven L Wickstrom; José J Escarce
Journal:  Arch Ophthalmol       Date:  2003-06

3.  The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration.

Authors:  Frank A Sloan; Brian W Hanrahan
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

4.  Use of eye care services among the 1991 Medicare population.

Authors:  L B Ellwein; V Friedlin; A M McBean; P P Lee
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Demographic predictors of eye care utilization among women.

Authors:  D A Schaumberg; W G Christen; R J Glynn; J E Buring
Journal:  Med Care       Date:  2000-06       Impact factor: 2.983

7.  Monitoring visual status: why patients do or do not comply with practice guidelines.

Authors:  Frank A Sloan; Derek S Brown; Emily Streyer Carlisle; Gabriel A Picone; Paul P Lee
Journal:  Health Serv Res       Date:  2004-10       Impact factor: 3.402

8.  Accuracy of coding in Medicare part B claims. Cataract as a case study.

Authors:  J C Javitt; A M McBean; S S Sastry; F DiPaolo
Journal:  Arch Ophthalmol       Date:  1993-05

9.  Old age and race as determinants of initiation of glaucoma therapy.

Authors:  R J Glynn; J H Gurwitz; R L Bohn; M Monane; I Choodnovskiy; J Avorn
Journal:  Am J Epidemiol       Date:  1993-09-15       Impact factor: 4.897

10.  Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases.

Authors:  Paul P Lee; Zachary W Feldman; Jan Ostermann; Derek S Brown; Frank A Sloan
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

View more
  10 in total

Review 1.  Current Challenges in Diabetic Retinopathy: Are We Really Doing Better?

Authors:  Jae Hyuck Lee; Su Jeong Song
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06-10

2.  Self-reported Use of Eye Care Among Adult Chinese Americans: The Chinese American Eye Study.

Authors:  Xuejuan Jiang; Rohit Varma; Mina Torres; Chunyi Hsu; Roberta McKean-Cowdin
Journal:  Am J Ophthalmol       Date:  2017-02-01       Impact factor: 5.258

3.  Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson's disease.

Authors:  Steven Beze; Lucia Castellani; Bruno Pereira; Frédéric Chiambaretta; Franck Durif; Ana Marques
Journal:  J Neurol       Date:  2022-03-16       Impact factor: 6.682

4.  Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes.

Authors:  Taichi Kawamura; Izumi Sato; Hiroshi Tamura; Yoko M Nakao; Koji Kawakami
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

5.  Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Anthony Obeid; Xinxiao Gao; Ferhina S Ali; Christopher M Aderman; Abtin Shahlaee; Murtaza K Adam; Sundeep K Kasi; Leslie Hyman; Allen C Ho; Jason Hsu
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

Review 6.  Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients.

Authors:  Yao Liu; Rebecca Swearingen
Journal:  Curr Diab Rep       Date:  2017-08-31       Impact factor: 4.810

7.  Awareness of Diabetic Retinopathy: Insight From the National Health and Nutrition Examination Survey.

Authors:  Kristen M J H Nwanyanwu; Marcella Nunez-Smith; Thomas W Gardner; Mayur M Desai
Journal:  Am J Prev Med       Date:  2021-08-21       Impact factor: 5.043

8.  Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006-2013.

Authors:  Su Jeong Song; Kyungdo Han; Kyung Seek Choi; Seung-Hyun Ko; Eun-Jung Rhee; Cheol-Young Park; Joong-Yeol Park; Ki-Up Lee; Kyung-Soo Ko
Journal:  J Diabetes Investig       Date:  2017-06-15       Impact factor: 4.232

9.  Disparities in Receipt of Eye Exams Among Medicare Part B Fee-for-Service Beneficiaries with Diabetes - United States, 2017.

Authors:  Elizabeth A Lundeen; John Wittenborn; Stephen R Benoit; Jinan Saaddine
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-15       Impact factor: 17.586

10.  Analysis of Health System Size and Variability in Diabetic Eye Disease Screening in Wisconsin.

Authors:  Loren J Lock; Mark Banghart; Roomasa Channa; Maureen A Smith; Meghan B Brennan; Alejandra Torres Diaz; Yao Liu
Journal:  JAMA Netw Open       Date:  2022-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.